Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...

Treosulfan (Grafapex) was approved in Canada in June 2021 for the same use and is marketed under the brand name Trecondyv.

Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, equitable care strategies and tailored treatment approaches.

Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...

The King Salman Humanitarian Aid and Relief Center (KSRelief) has launched three medical volunteer programs in Damascus, Syria, focusing on cochlear implants and auditory rehabilitation, pediatric ...